Simmons Jeffrey N 4

What Happened Jeffrey N. Simmons, President, CEO and Director of Elanco Animal Health Inc. (ELAN), was granted 109.891 deferred stock units on 2026-02-06. The award is reported at a per-unit value of $25.20 for a total reported value of $2,769. This transaction is coded as an award/acquisition (A) and is a derivative grant (deferred stock units), not an open-market purchase.

Key Details

• Transaction date: 2026-02-06; Form 4 filed: 2026-02-10 (timely filing).
• Amount: 109.891 deferred stock units at $25.20 each; total reported value $2,769.
• Transaction type/code: A (award/acquisition); classified as a derivative.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes:
  • F1 — Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent.
  • F2 — Units settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.

Context Deferred stock units are typically part of executive compensation and represent a future right to stock or cash; they do not represent immediate share ownership or an open-market purchase. Such awards are common as part of retention and compensation programs and should be interpreted as compensation-related rather than a direct market buy/sell signal.